BA
The Boeing Company
BA has the edge over MRTN overall, supported by stronger valuation and stronger fundamentals.
MRTN
Marten Transport, Ltd.
MRTN has lower modeled downside risk, despite its lower overall score.
BA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Under pressure |
BA's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is under pressure.
MRTN Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Stable | |
| Strong |
MRTN's balance sheet is currently strong, and its revenue, profitability and cash flow are stable.
BA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $172 | — |
| Cheap | 51x | $496 | +189% |
| Fair | 82x | $790 | +360% |
| Expensive | 91x | $876 | +411% |
Historical ranges are pointers, not guarantees.
BA has the edge over MRTN in the historical PE scenario, which offers more potential upside but is not a forecast.
MRTN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $2.77 | -77% |
| Fair | 21x | $3.54 | -70% |
| Forward | 28x | $11.93 | — |
| Expensive | 50x | $8.45 | -29% |
| Current | 70x | $11.93 | — |
Historical ranges are pointers, not guarantees.
MRTN's PE is in its expensive range at 70x. If earnings grow as analysts expect, today's price would be 28x next year's earnings.
BA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect BA to return to profit, with revenue growing. However, they disagree widely on these estimates.
MRTN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for MRTN, with profitability improving.
BA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $9.66 | +$23.38 |
| Q2 2026 | $2.78 | +$19.33 |
| Q1 2026 | $2.53 | +$20.49 |
| Q4 2025 | $2.48 | +$20.84 |
| Q3 2025 | -$13.72 | -$0.83 |
| Q2 2025 | -$16.55 | -$10.93 |
| Q1 2025 | -$17.96 | -$14.42 |
| Q4 2024 | -$18.36 | -$14.69 |
BA has the edge over MRTN on earnings, with more consistent year-over-year improvement.
MRTN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.43 | +155% |
| Q3 2026 | $0.17 | -26% |
| Q2 2026 | $0.16 | -36% |
| Q1 2026 | $0.18 | -31% |
| Q4 2025 | $0.21 | -36% |
| Q3 2025 | $0.23 | -44% |
| Q2 2025 | $0.25 | -53% |
| Q1 2025 | $0.26 | -63% |
| Q4 2024 | $0.33 | -62% |
MRTN's earnings per share have fallen from their peak: $0.17 over the past year, against $1.35 in late 2022.
BA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.2B | +3.9% |
| Q2 2026 | $24.6B | +8% |
| Q1 2026 | $22.2B | +14% |
| Q4 2025 | $23.9B | +57% |
| Q3 2025 | $23.3B | +30% |
| Q2 2025 | $22.7B | +35% |
| Q1 2025 | $19.5B | +18% |
| Q4 2024 | $15.2B | -31% |
BA has the edge over MRTN on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.5% | +22 points |
| Q2 2026 | 0.6% | +1.4 points |
| Q1 2026 | 2% | -0.3 points |
| Q4 2025 | 37% | +61 points |
| Q3 2025 | -21% | +12 points |
| Q2 2025 | -0.8% | +5.7 points |
| Q1 2025 | 2.4% | +2.9 points |
| Q4 2024 | -25% | -26 points |
BA has the edge over MRTN on profitability, with a higher operating margin.
MRTN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $223.2M | +1.3% |
| Q2 2026 | $223.5M | -2.8% |
| Q1 2026 | $203.5M | -8.8% |
| Q4 2025 | $210.1M | -8.8% |
| Q3 2025 | $220.5M | -7.1% |
| Q2 2025 | $229.9M | -6.6% |
| Q1 2025 | $223.2M | -11% |
| Q4 2024 | $230.4M | -14% |
MRTN's revenue has slid since its 2022 peak: $223M last quarter, up 1.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.4% | +0.1 points |
| Q2 2026 | 3.1% | -1.1 points |
| Q1 2026 | 0.8% | -1.8 points |
| Q4 2025 | 2.2% | -0.7 points |
| Q3 2025 | 1.2% | -0.6 points |
| Q2 2025 | 4.2% | +0.2 points |
| Q1 2025 | 2.6% | -2.3 points |
| Q4 2024 | 2.9% | -2.9 points |
MRTN's operating margin was 1.4% last quarter, about level with the same quarter a year ago, near the bottom of its range since 2019.
BA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $464M | +95% |
| Q2 2026 | $631M | +$831M |
| Q1 2026 | -$1.5B | +$836M |
| Q4 2025 | $375M | +$4.5B |
| Q3 2025 | $238M | +$2.2B |
| Q2 2025 | -$200M | +$4.1B |
| Q1 2025 | -$2.3B | +$1.6B |
| Q4 2024 | -$4.1B | -239% |
BA has the edge over MRTN on cash flow, with more consistent year-over-year improvement.
MRTN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $22.6M | +22% |
| Q2 2026 | $27.7M | -17% |
| Q1 2026 | $33M | -8.7% |
| Q4 2025 | $5.6M | -77% |
| Q3 2025 | $18.5M | -37% |
| Q2 2025 | $33.2M | -7.4% |
| Q1 2025 | $36.2M | -21% |
| Q4 2024 | $23.8M | -37% |
MRTN's free cash flow has been positive every quarter for seven years: $89M over the past year, down 20% from the year before.
BA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +2.1M shares |
| 1 year | +4.3% | +32.8M shares |
| 3 years | +31% | +186M shares |
| 5 years | +35% | +204M shares |
| Available history | +40% | +227M shares |
BA has 793M diluted shares, up 4.3% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
MRTN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +30K shares |
| 1 year | +0.2% | +137K shares |
| 3 years | +0.3% | +210K shares |
| 5 years | -2% | -1.7M shares |
| Available history | -1.2% | -1M shares |
MRTN has the edge over BA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $16.8M |
| Q1 2022 | $25M |
BA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 6.0x | High |
| Q4 2025 | 6.9x | High |
| Q2 2024 | 361.8x | High |
| Q1 2024 | 36.1x | High |
| Q4 2023 | 36.4x | High |
| Q3 2023 | 96.1x | High |
BA's net debt is about 3.0 years of its operating earnings (EBITDA), down from more than 20 years a year ago.
MRTN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.8x | Net Cash |
| Q2 2026 | -0.9x | Net Cash |
| Q1 2026 | -0.6x | Net Cash |
| Q4 2025 | -0.3x | Net Cash |
| Q3 2025 | -0.4x | Net Cash |
| Q2 2025 | -0.3x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | -0.1x | Net Cash |
MRTN has the edge over BA on leverage, with a lower net debt burden relative to earnings.
BA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.1 | Neutral |
| Stochastic | 9.6 | Oversold |
BA's weekly RSI is 31 (neutral) and its Stochastic is 10 (oversold).
MRTN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.3 | Neutral |
| Stochastic | 18.3 | Oversold |
MRTN's weekly RSI is 34 (neutral) and its Stochastic is 18 (oversold).
BA PE vs Industrials Sector
| Metric | BA | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 24x | 26% below |
| PE % | 0 | 58 | 58 pts below |
BA has the edge over MRTN on valuation relative to its sector.
MRTN PE vs Industrials Sector
| Metric | MRTN | Sector median | Relative |
|---|---|---|---|
| PE | 70x | 24x | 192% above |
| PE % | 93 | 58 | 35 pts above |
MRTN is trading at 70x earnings, a 192% premium to the Industrials sector's median of 24x.
BA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $184.6 | 7.1% below |
| 20 week MA | $203.8 | 16% below |
| 50 week MA | $215.5 | 20% below |
| 100 week MA | $205.9 | 17% below |
| 200 week MA | $200.6 | 14% below |
BA is in a downtrend: it's below all five of its weekly moving averages, and 14% below its 200-week average.
MRTN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $12.4 | 3.6% below |
| 20 week MA | $14.2 | 16% below |
| 50 week MA | $14.1 | 15% below |
| 100 week MA | $13.5 | 11% below |
| 200 week MA | $16.4 | 27% below |
MRTN is in a downtrend: it's below all five of its weekly moving averages, and 27% below its 200-week average.
BA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $330.1 | $217.2 | -34% |
| 2021 | $217.2 | $204.2 | -6% |
| 2022 | $204.2 | $189.1 | -7.4% |
| 2023 | $189.1 | $260.7 | +38% |
| 2024 | $260.7 | $180.7 | -31% |
| 2025 | $180.7 | $216.4 | +20% |
| 2026 YTD | $216.4 | $171.6 | -21% |
BA has finished lower in four of the last six years. It's down 21% so far in 2026.
MRTN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $14.4 | $17.2 | +19% |
| 2021 | $17.2 | $16.6 | -3.2% |
| 2022 | $16.6 | $20.0 | +20% |
| 2023 | $20.0 | $21.0 | +4.8% |
| 2024 | $21.0 | $15.6 | -26% |
| 2025 | $15.6 | $11.4 | -27% |
| 2026 YTD | $11.4 | $11.9 | +4.4% |
MRTN has the edge over BA on returns for 2026, with the stronger performance.